InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
83.10
(
-0.04%
)
Bitcoin
63,920.06
(
-0.12%
)
Post# of 19856
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ombowstring

Send PM Follow Ignore
Followers 24
Posts 5031
Boards Moderated 0
Alias Born 09/27/2005

ombowstring

Re: gfp927z post# 18735

Wednesday, 02/24/2021 12:11:19 PM

Wednesday, February 24, 2021 12:11:19 PM

Post# of 19856
This guy is admittedly long, goes under the alias of Chess Master, but writes for Insider Financial -

https://insiderfinancial.com/leronlimab-trial-results-all-but-certain-pointing-to-approval-for-cytodyn/181078/

"In an interview the CEO, Nader Pourhassan said that the FDA asked for a review of the data before disclosing the results."
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up